Education
About Us
Working with TipRanks
Follow Us
HemoGenyx Pharmaceuticals Plc (GB:HEMO)
LSE:HEMO
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | £ 0.00 | £ 0.00 | £ 0.00 | £ 0.00 | £ 0.00 |
| Gross Profit | £ -639.28K | £ -645.68K | £ -2.60M | £ -283.65K | £ -350.72K |
| Operating Income | £ -5.73M | £ -5.56M | £ 4.00M | £ -2.70M | £ -2.15M |
| EBITDA | £ -4.71M | £ -5.73M | £ -3.42M | £ -2.39M | £ -1.96M |
| Net Income | £ -5.62M | £ -6.69M | £ -4.35M | £ -7.52M | £ -2.12M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | £ 159.26K | £ 1.25M | £ 2.53M | £ 6.84M | £ 1.81M |
| Total Assets | £ 4.21M | £ 6.11M | £ 7.09M | £ 8.52M | £ 2.66M |
| Total Debt | £ 2.62M | £ 2.95M | £ 3.42M | £ 10.15K | £ 1.63M |
| Net Debt | £ 2.46M | £ 1.70M | £ 890.08K | £ -6.83M | £ -184.17K |
| Total Liabilities | £ 3.36M | £ 3.32M | £ 3.85M | £ 352.84K | £ 1.79M |
| Stockholders' Equity | £ 897.51K | £ 2.82M | £ 3.28M | £ 8.19M | £ 890.84K |
| Cash Flow | |||||
| Free Cash Flow | £ -4.13M | £ -6.22M | £ -3.34M | £ -3.45M | £ -1.97M |
| Operating Cash Flow | £ -4.12M | £ -6.11M | £ -2.91M | £ -2.63M | £ -1.80M |
| Investing Cash Flow | £ -24.90K | - | £ -420.25K | £ -938.95K | £ -169.68K |
| Financing Cash Flow | £ 3.08M | £ 4.45M | £ -110.14K | £ 8.78M | £ 3.21M |